Sign In

Frauke Hein

Chief Business Officer and cofounder at Adrenomed AG

Professional Background

Frauke Hein is an accomplished biopharma and diagnostics executive, recognized for her entrepreneurial spirit and a comprehensive, cross-functional approach to the ever-evolving landscape of biotechnology. With an impressive career spanning multiple organizations and roles, her extensive leadership expertise is particularly noteworthy in translating effective research and development (R&D) into comprehensive strategic product and business planning. Inspired by a commitment to innovation, Frauke combines deep scientific understanding with a keen commercial perspective, making her a pivotal figure in connecting R&D projects with corporate strategy and business development.

As the Chief Business Officer and co-founder of Adrenomed AG, Frauke has played an integral role in guiding the company's vision and strategy in the biopharma space. Her ability to effectively bridge scientific endeavors with market needs positions her as an expert in aligning research outputs with tangible business results. This role is a continuation of her passion for facilitating groundbreaking advancements in health technology and diagnostics, as she has always sought to foster a culture that thrives on innovation and scientific rigor.

Education and Achievements

Frauke's educational background is rooted in a strong foundation in life sciences; she earned a Doctor of Philosophy (PhD) in Biotechnology and Biochemistry of Plants from the University of Münster, where she developed critical research skills that would later inform her leadership in product development and strategic planning. Prior to her PhD, she obtained a Diploma in Biology from the same esteemed institution, further cementing her scientific expertise.

Throughout her career, Frauke has held several high-profile roles that showcase her depth of knowledge in biotechnology and diagnostics. She previously served on the Advisory Board of the InfectoGnostics Research Campus Jena, where she contributed to fostering innovation and collaboration within the life sciences sector. As a Venture Advisor at NLC, a European health tech venture builder, she leveraged her insights to bolster new ventures, demonstrating her commitment to fostering growth in the health technology landscape.

Among her many accomplishments, Frauke also contributed as a Jury Member for the Healthcare category of the Berlin Brandenburg Region Innovation Award. In this capacity, she helped identify and promote impactful innovations shaping the future of healthcare, further solidifying her reputation as a thought leader in biotechnology. As a Board Member of the InfectControl2020 Research Consortium, she played a crucial role in steering initiatives aimed at tackling infectious diseases through innovative R&D.

Previously, as the Director of Portfolio Management at Deutsche Biotech Innovativ AG, Frauke exhibited her skills in strategic oversight, ensuring that product pipelines align with market demands and scientific advancements. Her tenure as the Director of Project Coordination R&D at Thermo Fisher Scientific showcased her aptitude for managing complex projects that are critical to the advancement of clinical diagnostics and biomarkers.

Her career also includes significant contributions as the Director of Research & Development at BRAHMS AG, where she oversaw R&D initiatives that drove innovation in diagnostics. This role not only enhanced her technical expertise but also underscored her ability to lead teams towards impactful outcomes.

Throughout her impressive career, Frauke gained valuable experience in project management as a Biotechnology Project Manager at T.IN.A. Technology and Innovations Agency Brand, where she led initiatives to harness new technologies for the biotechnology sector.

Achievements

Frauke Hein’s achievements in the biopharma and diagnostics sector are numerous and reflect her dedication to both scientific excellence and business success. Her role at Adrenomed AG exemplifies her entrepreneurial capabilities and commitment to driving innovation in health technology, vital for addressing current healthcare challenges.

In her advisory and board roles, she has had a notable impact on fostering collaboration and innovation within the research community. Her participation in various research consortia, innovation awards, and as a venture advisor illustrates her deep commitment to the biotechnology field and her belief in the importance of linking research with market needs.

Her leadership style is characterized by a desire to synergize effective R&D translation, which has led to successful product developments and a stronger company vision aligned with strategic goals. This 360-degree perspective, which encompasses scientific rigor and market-oriented strategies, makes her a valuable asset in any organization she is part of.

Frauke's commitment to continuous learning and her inquisitive nature drive her to stay ahead of industry trends and technological advancements. This not only benefits her own professional development but also inspires those around her to embrace innovation and adapt to the changing landscape of healthcare.

In summary, Frauke Hein stands out as a prominent leader in the biopharma and diagnostics industry. Her robust educational foundation, combined with leadership roles in influential organizations, underscores her ability to bridge the gap between complex scientific research and business strategy effectively. Her contributions continue to shape the future of biotechnology and health technology, making her a key figure in improving healthcare outcomes through strategic innovation.

Related Questions

How did Frauke Hein’s educational background influence her career in biopharma and diagnostics?
What innovative strategies has Frauke Hein implemented as the Chief Business Officer of Adrenomed AG?
How did Frauke Hein contribute to the InfectoGnostics Research Campus Jena during her time on the Advisory Board?
What experiences have shaped Frauke Hein's commercial perspective in the biotechnology sector?
In what ways has Frauke Hein fostered collaboration in the healthcare innovation space as a Jury Member for the Berlin Brandenburg Region Innovation Award?
Frauke Hein
Add to my network

Location

Berlin Metropolitan Area